CRESCENT BIOPHARMA, INC. — All Filings
625 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
3
4
4/A
424B3
424B4
424B5
425
5
8-A12B
8-A12B/A
8-K
ARS
CERTNAS
CORRESP
CT ORDER
D
D/A
DEF 14A
DEFA14A
DRS
EFFECT
FWP
POS AM
POS EX
PRE 14A
REGDEX
S-1
S-1/A
S-3
S-4
S-4 POS
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 424B3 | 424B3 | 0001628280-26-018693 | Mar 17, 2026 | — |
| EFFECT | — | 9999999995-26-000704 | Mar 3, 2026 | — |
| POS AM | POS AM | 0001628280-26-013540 | Mar 3, 2026 | — |
| 424B3 | 424B3 | 0001628280-26-012015 | Feb 26, 2026 | — |
| S-8 | S-8 | 0001628280-26-011991 | Feb 26, 2026 | — |
| 8-K | 8-K | 0001628280-26-011988 | Feb 26, 2026 | — |
| 10-K | 10-K | 0001628280-26-011983 | Feb 26, 2026 | Dec 31, 2025 |
| SCHEDULE 13G/A | — | 0001738048-26-000018 | Feb 17, 2026 | — |
| SCHEDULE 13G | — | 0000902664-26-001077 | Feb 17, 2026 | — |
| SCHEDULE 13G/A | — | 0000315066-26-000413 | Feb 5, 2026 | — |
| EFFECT | — | 9999999995-26-000182 | Jan 15, 2026 | — |
| 424B3 | 424B3 | 0001628280-26-002218 | Jan 15, 2026 | — |
| CORRESP | — | 0001628280-26-001951 | Jan 13, 2026 | — |
| UPLOAD | — | 0000000000-26-000353 | Jan 12, 2026 | — |
| S-1 | S-1 | 0001628280-26-001227 | Jan 7, 2026 | — |
| 4 | FORM 4 | 0001628280-25-057687 | Dec 17, 2025 | Dec 15, 2025 |
| 4 | FORM 4 | 0001628280-25-057685 | Dec 17, 2025 | Dec 15, 2025 |
| 4 | FORM 4 | 0001628280-25-057683 | Dec 17, 2025 | Dec 15, 2025 |
| 4 | FORM 4 | 0001628280-25-057681 | Dec 17, 2025 | Dec 15, 2025 |
| 4 | FORM 4 | 0001628280-25-057678 | Dec 17, 2025 | Dec 15, 2025 |
| 4 | FORM 4 | 0001628280-25-057673 | Dec 17, 2025 | Dec 15, 2025 |
| 4 | FORM 4 | 0001628280-25-057671 | Dec 17, 2025 | Dec 15, 2025 |
| 4 | FORM 4 | 0001628280-25-057669 | Dec 17, 2025 | Dec 15, 2025 |
| S-4 POS | S-4 POS | 0001628280-25-056652 | Dec 12, 2025 | — |
| SCHEDULE 13G | — | 0001193125-25-315863 | Dec 11, 2025 | — |
| 4 | FORM 4 | 0001628280-25-056333 | Dec 10, 2025 | Dec 8, 2025 |
| 4 | FORM 4 | 0001628280-25-056331 | Dec 10, 2025 | Dec 8, 2025 |
| SCHEDULE 13D/A | — | 0001104659-25-119323 | Dec 8, 2025 | — |
| 4 | OWNERSHIP DOCUMENT | 0001104659-25-119320 | Dec 8, 2025 | Dec 4, 2025 |
| 8-K | 8-K | 0001628280-25-055221 | Dec 4, 2025 | Dec 2, 2025 |
| S-8 | S-8 | 0001628280-25-049876 | Nov 6, 2025 | — |
| 8-A12B/A | 8-A12B/A | 0001628280-25-049873 | Nov 6, 2025 | — |
| 10-Q | 10-Q | 0001628280-25-049868 | Nov 6, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001628280-25-049865 | Nov 6, 2025 | — |
| SCHEDULE 13G/A | — | 0001214659-25-014932 | Oct 14, 2025 | — |
| SCHEDULE 13G | — | 0001214659-25-014813 | Oct 9, 2025 | — |
| SCHEDULE 13G | — | 0001214659-25-012492 | Aug 20, 2025 | — |
| SCHEDULE 13G/A | — | 0000921895-25-002280 | Aug 14, 2025 | — |
| SCHEDULE 13G/A | — | 0000935836-25-000528 | Aug 14, 2025 | — |
| 8-K | 8-K | 0001628280-25-036846 | Jul 31, 2025 | Jul 29, 2025 |
| 10-Q | 10-Q | 0001628280-25-036839 | Jul 31, 2025 | Jun 30, 2025 |
| 4 | OWNERSHIP DOCUMENT | 0001104659-25-068426 | Jul 16, 2025 | — |
| 3 | OWNERSHIP DOCUMENT | 0001104659-25-068102 | Jul 15, 2025 | Jul 7, 2025 |
| SCHEDULE 13G | — | 0000315066-25-001679 | Jul 8, 2025 | — |
| 3 | OWNERSHIP DOCUMENT | 0001104659-25-064138 | Jun 30, 2025 | Jun 13, 2025 |
| 3 | OWNERSHIP DOCUMENT | 0001104659-25-064118 | Jun 30, 2025 | Jun 13, 2025 |
| 4 | OWNERSHIP DOCUMENT | 0001104659-25-061820 | Jun 23, 2025 | — |
| 4 | OWNERSHIP DOCUMENT | 0001104659-25-061819 | Jun 23, 2025 | — |
| 4 | OWNERSHIP DOCUMENT | 0001104659-25-061818 | Jun 23, 2025 | — |
| 4 | OWNERSHIP DOCUMENT | 0001104659-25-061817 | Jun 23, 2025 | — |